Form S-4/A Carisma Therapeutics
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20250829/AJ2ZAQ2CH222VZZ222292Z4ZOVDQZ2H2GX72
Filed on: August 29, 2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carmila: Information Concerning the Total Number of Voting Rights and Share
- Fresenius Kabi Issues Nationwide Recall of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL Vials Due to Presence of Glass Particles
- KBRA Assigns Preliminary Ratings to FCR 2026-FL1
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
